Literature DB >> 8453763

Developmentally regulated expression of pleiotrophin, a novel heparin binding growth factor, in the nervous system of the rat.

A Wanaka1, S L Carroll, J Milbrandt.   

Abstract

Pleiotrophin (PTN) is a newly identified heparin-binding growth factor which is closely related to the retinoic acid-inducible MK protein. PTN is expressed at high levels in perinatal brain and promotes neurite outgrowth from embryonic brain neurons and mitogenesis in fibroblasts, suggesting that it may play an important role in the development of the nervous system. We have used in situ hybridization to examine PTN expression in the developing and adult rat nervous systems. During embryogenesis, PTN mRNA is primarily expressed by neuroglial progenitor cells in the subependymal layer of the central nervous system (CNS), whereas during the perinatal period high levels of PTN transcripts are found in neurons as well as glial elements (astrocytes and oligodendrocytes). In the adult brain, PTN expression is markedly decreased relative to early postnatal brain and, in contrast to the neuronal and glial expression observed in young animals, is confined to specific neuronal subpopulations (especially hippocampal CA1-3 regions, cerebral cortex laminae II-IV). PTN is also expressed in the developing spinal cord and eye. In the peripheral nervous system (PNS), PTN mRNA is present in ganglionic neurons during embryogenesis. In adult ganglia, however, PTN expression becomes localized to the satellite cells of the ganglia. The developmental pattern of PTN expression in the CNS and the 'switch' in expression from neurons to satellite cells in the PNS suggests that it has important functions not only in the developing nervous system, but also in the adult CNS and PNS and that the functions performed by this growth factor change during ontogeny. We have also found that levels of PTN mRNA are dramatically but transiently elevated in neurons of the hippocampus, piriform cortex and parietal cortex following a chemically induced seizure, indicating that neuronal PTN mRNA expression is increased by intense physiological stimuli and may play a role in the response to these stimuli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453763     DOI: 10.1016/0165-3806(93)90166-8

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  12 in total

1.  A transcription-dependent switch controls competence of adult neurons for distinct modes of axon growth.

Authors:  D S Smith; J H Skene
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

2.  Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury.

Authors:  H J Yeh; Y Y He; J Xu; C Y Hsu; T F Deuel
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

3.  Role of Chondroitin Sulfate (CS) Modification in the Regulation of Protein-tyrosine Phosphatase Receptor Type Z (PTPRZ) Activity: PLEIOTROPHIN-PTPRZ-A SIGNALING IS INVOLVED IN OLIGODENDROCYTE DIFFERENTIATION.

Authors:  Kazuya Kuboyama; Akihiro Fujikawa; Ryoko Suzuki; Naomi Tanga; Masaharu Noda
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

4.  The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.

Authors:  Peter Landgraf; Petra Wahle; Hans-Christian Pape; Eckart D Gundelfinger; Michael R Kreutz
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

5.  Pleiotrophin is a neurotrophic factor for spinal motor neurons.

Authors:  Ruifa Mi; Weiran Chen; Ahmet Höke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

Review 6.  Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin.

Authors:  F Czubayko; A M Schulte; S C Missner; S S Hsieh; K J Colley; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

7.  Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian rats.

Authors:  Irene Re Taravini; Mariela Chertoff; Eduardo G Cafferata; José Courty; Mario G Murer; Fernando J Pitossi; Oscar S Gershanik
Journal:  Mol Neurodegener       Date:  2011-06-07       Impact factor: 14.195

Review 8.  Pleiotrophin as a central nervous system neuromodulator, evidences from the hippocampus.

Authors:  Celia González-Castillo; Daniel Ortuño-Sahagún; Carolina Guzmán-Brambila; Mercè Pallàs; Argelia Esperanza Rojas-Mayorquín
Journal:  Front Cell Neurosci       Date:  2015-01-08       Impact factor: 5.505

9.  Identification of direct regulatory targets of the transcription factor Sox10 based on function and conservation.

Authors:  Kyung Eun Lee; Seungyoon Nam; Eun-ah Cho; Ikjoo Seong; Jin-Kyung Limb; Sanghyuk Lee; Jaesang Kim
Journal:  BMC Genomics       Date:  2008-09-11       Impact factor: 3.969

10.  Behavioral and neuroanatomical abnormalities in pleiotrophin knockout mice.

Authors:  Jason W Krellman; Henry H Ruiz; Veronica A Marciano; Bracha Mondrow; Susan D Croll
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.